Sentiment-Signal
22,0
Stark Bearisch
Composite Score (0–100)
Insider (25%)
0
Keine Insider-Käufe
Institutionell (22,5%)
0
Keine neuen Positionen
Aktivist (12,5%)
0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,70% (Stand: 31.03.2026)
Score-Verlauf (90 Tage)
Kritische 8-K Meldungen
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 04.08.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Office |
| 16.06.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Office |
| 25.06.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Office |
Stammdaten
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. It operates in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was incorporated in 2012 and is headquartered in Boston, Massachusetts.
Unternehmen & Branche
| Name | 908 Devices Inc. |
|---|---|
| Ticker | MASS |
| CIK | 0001555279 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Medical - Devices |
| SIC | 3829 · Measuring & Controlling Devices, NEC |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 248,6 Mio. USD |
| Beta | 0,53 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 56,197,000 | 19,489,000 | 0.54 | 190,071,000 | 143,699,000 |
| 2025-09-30 | 10-Q | 14,005,000 | -14,982,000 | -0.41 | 190,873,000 | 136,299,000 |
| 2025-06-30 | 10-Q | 13,035,000 | -13,306,000 | -0.37 | 191,701,000 | 148,817,000 |
| 2025-03-31 | 10-Q | 11,777,000 | 43,603,000 | 1.23 | 196,027,000 | 159,424,000 |
| 2024-12-31 | 10-K | 47,746,000 | -72,206,000 | -2.12 | 159,476,000 | 114,592,000 |
| 2024-09-30 | 10-Q | 14,519,000 | -29,295,000 | -0.84 | 178,283,000 | 131,039,000 |
| 2024-06-30 | 10-Q | 11,462,000 | -12,548,000 | -0.37 | 208,774,000 | 156,359,000 |
| 2024-03-31 | 10-Q | 7,422,000 | -10,917,000 | -0.33 | 189,791,000 | 156,893,000 |
| 2023-12-31 | 10-K | 50,229,000 | -36,399,000 | -1.13 | 202,981,000 | 165,491,000 |
| 2023-12-31 | 10-Q | -36,400,000 | 202,981,000 | 165,491,000 | ||
| 2023-09-30 | 10-Q | 14,297,000 | -7,093,000 | -0.22 | 208,475,000 | 169,929,000 |
| 2023-06-30 | 10-Q | 12,094,000 | -9,346,000 | -0.29 | 210,830,000 | 174,459,000 |
| 2023-03-31 | 10-Q | 9,487,000 | -12,532,000 | -0.39 | 218,407,000 | 180,612,000 |
| 2022-12-31 | 10-Q | -33,600,000 | 242,587,000 | 190,599,000 | ||
| 2022-12-31 | 10-K | 46,852,000 | -33,563,000 | -1.07 | 242,587,000 | 190,599,000 |
| 2022-09-30 | 10-Q | 15,797,000 | -6,259,000 | -0.20 | 249,281,000 | 196,500,000 |
| 2022-06-30 | 10-Q | 11,106,000 | -8,099,000 | -0.26 | 246,995,000 | 201,115,000 |
| 2022-03-31 | 10-Q | 8,306,000 | -9,415,000 | -0.30 | 251,226,000 | 206,802,000 |
| 2021-12-31 | 10-Q | -22,200,000 | 260,906,000 | 214,604,000 | ||
| 2021-12-31 | 10-K | 42,206,000 | -22,169,000 | -0.79 | 260,906,000 | 214,604,000 |
Fondsaktivität (Vorquartalsvergleich)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-04-10 | McCallion Kevin J. | Officer, SVP, Products and Production | Open Market Sale | -2,693 | 7.01 | -18,877.93 | -30,1% | |
| 2026-04-10 | Brown Christopher D. | Director | Open Market Sale | -17,578 | 7.07 | -124,276.46 | -198,1% | |
| 2026-04-09 | Brown Christopher D. | Director | Open Market Sale | -7,392 | 7.04 | -52,039.68 | -83,0% | |
| 2026-04-09 | McCallion Kevin J. | Officer, SVP, Products and Production | Open Market Sale | -5,420 | 7.03 | -38,102.60 | -60,7% | |
| 2026-04-08 | McCallion Kevin J. | Officer, SVP, Products and Production | Open Market Sale | -18,580 | 7.05 | -130,989.00 | -208,8% | |
| 2026-04-08 | Brown Christopher D. | Director | Open Market Sale | -15,030 | 7.05 | -105,961.50 | -168,9% | |
| 2026-03-02 | McCallion Kevin J. | Officer, SVP, Products and Production | Open Market Sale | -7 | 7.00 | -49.00 | -0,1% | |
| 2026-03-02 | McCallion Kevin J. | Officer, SVP, Products and Production | Open Market Sale | -7 | 7.00 | -49.00 | -0,1% | |
| 2026-02-02 | Griffith Joseph H. IV | Officer, Chief Financial Officer | Open Market Sale | -23,175 | 6.18 | -143,221.50 | -228,3% | |
| 2026-02-02 | Knopp Kevin J. | Director, Officer, President and CEO | Open Market Sale | -34,764 | 6.18 | -214,841.52 | -342,5% | |
| 2025-10-03 | Griffith Joseph H. IV | Officer, Chief Financial Officer | Open Market Sale | -4,292 | 9.05 | -38,849.04 | -61,9% | |
| 2025-10-02 | Griffith Joseph H. IV | Officer, Chief Financial Officer | Open Market Sale | -708 | 9.04 | -6,397.77 | -10,2% | |
| 2025-09-19 | Griffith Joseph H. IV | Officer, Chief Financial Officer | Open Market Sale | -5,000 | 7.07 | -35,338.50 | -56,3% | |
| 2025-06-18 | Turner Michael S. | Officer, Chief Legal & Admin Officer | Open Market Sale | -1,373 | 7.50 | -10,297.50 | -16,4% | |
| 2025-06-17 | Turner Michael S. | Officer, Chief Legal & Admin Officer | Open Market Sale | -7,148 | 7.51 | -53,652.89 | -85,5% | |
| 2025-06-16 | Turner Michael S. | Officer, Chief Legal & Admin Officer | Open Market Sale | -16,082 | 7.51 | -120,838.54 | -192,7% | |
| 2025-06-04 | Griffith Joseph H. IV | Officer, Chief Financial Officer | Open Market Sale | -6,940 | 7.08 | -49,135.20 | -78,3% | |
| 2025-05-15 | Knopp Kevin J. | Director, Officer, President and CEO | Open Market Purchase | 15,000 | 4.44 | 66,595.50 | +106,2% | |
| 2025-05-14 | Spoto Mark | Director | Open Market Purchase | 3,000 | 4.25 | 12,750.00 | +20,3% | |
| 2025-05-14 | Spoto Mark | Director | Open Market Purchase | 7,000 | 4.30 | 30,100.00 | +48,0% | |
| 2025-05-14 | Knopp Kevin J. | Director, Officer, President and CEO | Open Market Purchase | 15,000 | 4.32 | 64,788.00 | +103,3% |
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.